REGENXBIO director Daniel Abdun-Nabi will not stand for re-election at 2022 annual meeting

REGENXBIO Inc.

Daniel J. Abdun-Nabi informed REGENXBIO he will not stand for re-election at the 2022 annual meeting.
His term expires at the 2022 annual meeting; decision not due to any disagreement with the company.
He served nearly six years as a director; company thanked him for his service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel J. Abdun-Nabi

Director

RGNX · REGENXBIO Inc.

Filed: March 18, 2022, 7:59 PM ET

On March 14, 2022, Daniel J. Abdun-Nabi notified REGENXBIO Inc. (the “Company”) that he will not stand for re-election as a director of the Company at the end of his current term, which expires at the Company’s 2022 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel J. Abdun-Nabi departed as Director at REGENXBIO Inc..

Action: will not stand for re-election
Role: Director

Exact text from the filing

On March 14, 2022, Daniel J. Abdun-Nabi notified REGENXBIO Inc. (the “Company”) that he will not stand for re-election as a director of the Company at the end of his current term, which expires at the Company’s 2022 annual meeting of stockholders.

View on SEC.gov

REGENXBIO Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-079590

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.